The Real Cost of Cancer Screening: A False Positive Isn’t Cancer, but the Fear Is Real
Cancer screening is one of the most powerful tools we have for early detection, but every screening test comes with a tradeoff: false positives. A false positive means a test suggests something abnormal, but follow-up shows it is not cancer. For clinicians, it may be one step in a diagnostic workup. For patients, hearing “positive” can feel like a cancer scare.
“False positives may be the price we pay for finding cancer early, but we should always be working to lower that cost,” said Jason Hafron, MD, chief medical officer and medical director of Clinical Research at the Michigan Institute of Urology, and professor of urology at the William Beaumont School of Medicine at Oakland University.
What Are the Real Burdens of a False Positive?
In an interview, Hafron highlighted three frequently overlooked consequences:
- Emotional and psychological burden: Patients may experience immediate anxiety, sleep disruption, difficulty concentrating, and strain on family relationships. Even after cancer is ruled out, some continue to worry that something was missed.
- Clinical and financial burden: Confirming results may require additional imaging, lab tests, referrals, biopsies, or invasive procedures—exposing patients to risks, costs, and time away from work while consuming health care resources.
- Erosion of trust and future screening: Poor communication around a false positive can damage trust in screening programs. After repeated false positives, some patients become reluctant to participate in future screening, which carries its own risks.
Why Does the Word “Positive” Feel So Frightening?
Hafron explained that screening involves a tradeoff between sensitivity and specificity: the more aggressively we look for cancer, the more benign findings we find. That makes sense at a population level, but patients do not experience it that way.
“For them, a positive result is a cancer scare,” he said. Waiting for follow-up tests or biopsy results is often harder than the testing itself. Some patients carry anxiety for months or even years after being cleared, becoming hypervigilant about every new symptom.
How Can We Reduce the Harm of False Positives?
Hafron argued that the goal is not to find more abnormalities, but to find the right abnormalities. That requires more precise diagnostics and risk stratification, as well as clearer communication.
- More precise tests: The IsoPSA test, for example, analyzes the structure of prostate-specific antigen (PSA) proteins to help determine whether elevated PSA may be due to cancer or other factors. A single-center retrospective study showed that among 1,578 patients with elevated PSA who underwent IsoPSA testing, the risk of clinically significant prostate cancer was lower in those with initial low IsoPSA indices versus high indices.
- Other risk stratification tools: Tests such as Cx Bladder Triage aim to improve diagnostic specificity, helping distinguish clinically meaningful cancers from benign findings while preserving the benefits of early detection.
- Setting expectations early: Patients should understand before testing that false positives are an unavoidable part of effective screening and that the system is designed to catch and correct them. “Patients will tolerate uncertainty better than poor communication,” Hafron said. “How we explain a false positive often matters as much as the false positive itself.”
Which Screenings Carry the Greatest False-Positive Burden?
Hafron noted that several modalities can be associated with a significant burden, including lung cancer screening with low-dose CT and breast cancer screening. Risks vary by cancer type and screening method, making individualized assessment and clear communication essential.
Practical Takeaways for Patients
- Before screening, ask: What is the approximate false-positive rate? If results are abnormal, what are the next steps?
- Interpret “positive” as “needs further confirmation,” not “cancer diagnosed.”
- If anxiety significantly affects sleep, mood, or work, seek help from a clinician or mental health professional.
- Discuss with your doctor whether a more precise risk stratification test could help reduce unnecessary biopsies or invasive procedures.
Want to better manage post-screening anxiety and track changes in your health metrics? The Xiaoshu Health App can sync with Apple Health to track relevant indicators, helping you record sleep, heart rate, activity, and more for better conversations with your doctor.